Abraxis Bioscience announced the appointment of Rick Rodgers as Senior Vice President and Chief Financial Officer, succeeding David O'Toole. Rodgers most recently was Senior Vice President, Controller and Chief Accounting Officer of MGI Pharma until the company's acquisition by the Eisai Corporation in 2008.
Novo Nordisk announced a global workforce reduction of approximately 9,000 positions to streamline operations and reinvest DKK 8 billion (€1 billion) in growth opportunities for diabetes and obesity treatments.
Carbon black manufacturer Orion Engineered Carbons plans to rationalize production lines in North and South America and EMEA.
Compelling solutions through strategic partnerships
Building on the April 2025 announcement, Dow will take actions across its three operating segments to support European profitability, resulting in the closure of sites in Germany and the UK.
